A positive attitude may slow cognitive decline in MS
January 9, 2019
In a recent publication, investigators evaluated factors that might influence the change in a test called the Symbol Digit Modalities Test (SDMT) within a large group of patients with multiple sclerosis (MS). This test measures cognitive function, specifically processing speed, which is an area of cognition most commonly affected in MS. At least two SDMT tests from 531 patients were collected over the course of 16 years and the average time between tests was approximately three years. The...
High Dose Biotin again showed benefit in progressive multiple sclerosis in a small study in France
January 2, 2019
Jonathan Ciron, MD from Toulouse France presented their clinical findings in first 91 patients with primary or secondary progressive multiple sclerosis followed for one year on 300 mg day.They looked at EDSS, 25 foot timed walk, 9 hole peg test , number of relapses and gad lesions on MRI.Mean age was 59 yr, 61% were females. Mean EDSS was 5.9. An EDSS of 6 means needing cane to walk.After 1 year, 23% of patients improved on EDSS and 23% improved on 25 foot timed walk.This high dose vitamin...
Summary of a recent publication in Brain journal on our study looking at MS lesion pathology
December 26, 2018
Dr. Ulrike Kaunzner was the first author on a paper that has been published under the leadership of Dr. Susan Gauthier in the journal “Brain”, that combined two imaging techniques to shed better light on the presence of chronic active lesions in MS patients.
